The risk of developing heart problems was double for children taking methylphenidate for attention-deficit/hyperactivity disorder (ADHD) compared with children not prescribed the medicine.

The study builds on data from 714,000 children born in 1990-1999. It is the most comprehensive, data-based study within the field explains the head of the project Søren Dalsgaard, a psychiatrist at the National Center for Register-based Research at Aarhus University in Denmark.

READ FULL ARTICLE Curated publisher From Sharp Brains